Press release
Narcolepsy Therapeutics Market Rapidly Increasing In Size Globally (2020-2025) and Market Analysis by Teva, Addrenex Pharma, Jazz Pharma, Graymark Healthcare, Arena Pharma, Shire
Narcolepsy Therapeutics Market
Overview of Global Narcolepsy Therapeutics Market:
This report studies the Global Narcolepsy Therapeutics Market over the forecast period of 2020 to 2025. The Global Narcolepsy Therapeutics Market is expected to grow at an impressive Compound Annual Growth Rate (CAGR) from 2020 to 2025.
Most important key factors driving the growth of the Global Narcolepsy Therapeutics Market are growing awareness about sleep disorders, increasing prevalence of these disorders due to unhealthy lifestyle, surge in stress levels, growing demand for advanced therapies for sleeping disorders, extensive efforts of government & non-governmental organizations for spreading awareness about the disease, increasing R&D activities o find a cure for narcolepsy.
Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/270746 .
The Global Narcolepsy Therapeutics Market is segmented on the basis of Type, Application and Region. Based on the Type, the Global Narcolepsy Therapeutics Market is sub-segmented into Central nervous system stimulants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor (SSRI), Tricyclic Antidepressants and others. On the basis of Application, the Global Narcolepsy Therapeutics Market is classified into Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, Secondary Narcolepsy and others.
In terms of the geographic analysis, The Narcolepsy Therapeutics Market in North America is expected to grow at the highest CAGR during the forecast period. Moreover, the presence of major players in the Narcolepsy Therapeutics Market ecosystem results in the increasing adoption of these systems in North America.
Global Narcolepsy Therapeutics Market Objectives:
1 To provide detailed information regarding key factors (drivers, restraints, opportunities, and industry-specific challenges) influencing the growth of the Narcolepsy Therapeutics Market
2 To analyze and forecast the size of the Narcolepsy Therapeutics Market, in terms of value and volume
3 To analyze opportunities in the Narcolepsy Therapeutics Market for stakeholders and provide a competitive landscape of the market
4 To define, segment, and estimate the Narcolepsy Therapeutics Market based on deposit type and end-use industry
5 To strategically profile key players and comprehensively analyze their market shares and core competencies
6 To strategically analyze micromarkets with respect to individual growth trends, prospects, and contribution to the total market
7 To forecast the size of market segments, in terms of value, with respect to main regions, namely, Asia Pacific, North America, Europe, the Middle East & Africa, and South America
8 To track and analyze competitive developments, such as new product developments, acquisitions, expansions, partnerships, and collaborations in the Narcolepsy Therapeutics Market
Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Narcolepsy Therapeutics Market Report 2020” @ https://www.businessindustryreports.com/buy-now/270746/single .
Top Leading Key Manufacturers are: Addrenex Pharmaceuticals, Teva, Jazz Pharmaceuticals, Graymark Healthcare, Arena Pharmaceuticals, BIOPROJET, Shire, Ligand Pharmaceuticals and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Worldwide Medical Industry News:
Teva Pharmaceutical (May 25, 2020) - Teva Presented New Data at the European Academy of Neurology Congress Evaluating the AJOVY (fremanezumab) Experience in Populations with Difficult-to-Treat Migraine - Teva Pharmaceutical Industries Ltd. presented a wide range of important new data on AJOVY (fremanezumab) and the societal and economic impact of migraine in Europe at the 6th Congress of the European Academy of Neurology (EAN). This year’s EAN congress was a virtual meeting due to the global coronavirus pandemic.
The fremanezumab data included pooled analyses of the AJOVY Phase 3 clinical trials (FOCUS, HALO-episodic migraine (EM) and HALO-chronic migraine (CM)) which focused on the safety, efficacy and improved quality-of-life for patients experiencing difficult-to-treat migraine. Post-hoc analyses were also evaluated in patients who may experience challenges when managing their migraine due to comorbidities.
Migraine creates a significant disease and economic burden. With more than one billion people impacted globally, migraine is the second leading global cause of years lived with disability and annual costs of the disease in the U.S. and EU are $200 billion.
“Migraine imposes physical, emotional and societal burdens worldwide and yet available treatment options are often unsatisfactory for many patients,” said Joshua M. Cohen, MD, MPH, FAHS, Senior Director, Global Medical Affairs – Therapeutic Area Lead Migraine & Headache, Teva. “As a leader in neurology and migraine treatment, Teva’s goal is to continue evaluating the impact of AJOVY across various patient populations to ensure that reliable and relevant information is available to healthcare professionals when considering treatment options.”
Region segment: This report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Narcolepsy Therapeutics in these regions, from 2013 to 2025 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America
Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/270746 .
Major Points in Table of Contents:
Global Narcolepsy Therapeutics Market Report 2020
1 Narcolepsy Therapeutics Product Definition
2 Global Narcolepsy Therapeutics Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Narcolepsy Therapeutics Shipments
2.2 Global Manufacturer Narcolepsy Therapeutics Business Revenue
2.3 Global Narcolepsy Therapeutics Market Overview
2.4 COVID-19 Impact on Narcolepsy Therapeutics Industry
3 Manufacturer Narcolepsy Therapeutics Business Introduction
3.1 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Business Introduction
3.2 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Business Introduction
3.3 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Business Introduction
3.4 Graymark Healthcare, Inc. Narcolepsy Therapeutics Business Introduction
3.5 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Business Introduction
3.6 BIOPROJET Narcolepsy Therapeutics Business Introduction
………………. Request free sample to get a complete Table of Content
About us
BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.
Media Contact
Business Industry Reports
Pune – India
sales@businessindustryreports.com
+19376349940
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Narcolepsy Therapeutics Market Rapidly Increasing In Size Globally (2020-2025) and Market Analysis by Teva, Addrenex Pharma, Jazz Pharma, Graymark Healthcare, Arena Pharma, Shire here
News-ID: 2080091 • Views: …
More Releases from Business Industry Reports
Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,…
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market:
This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization.
According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities…
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market:
This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization.
According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,…
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis:
The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast…
More Releases for Narcolepsy
Key Trends Shaping the Future Narcolepsy Market From 2025-2034: Development Of E …
What industry-specific factors are fueling the growth of the narcolepsy market?
The rising number of obese individuals is expected to fuel the growth of the narcolepsy market. Obesity is increasing due to poor dietary habits, sedentary lifestyles, and environmental factors. Obesity can disrupt sleep patterns and lead to narcolepsy. The World Health Organization's March 2022 report indicated that approximately 1 billion people worldwide are obese, with the number continuing to rise.…
Obesity Fueling Narcolepsy Market Growth Driver: Leading Transformation in the N …
What Are the Projected Growth and Market Size Trends for the Narcolepsy Market?
The narcolepsy market has experienced swift expansion over the past few years. The market is projected to increase from $3.56 billion in 2024 to $3.99 billion in 2025, correspondingly reflecting a compound annual growth rate (CAGR) of 12.0%. The significant growth observed during the historic period is due to several factors, including heightened awareness regarding narcolepsy, advancements…
Major Force in the Narcolepsy Drugs Market 2025: Growing Demand For Personalized …
How Will the Narcolepsy Drugs Market Grow, and What Is the Projected Market Size?
In the last few years, the narcolepsy pharmaceuticals market has demonstrated robust growth. The market value, which stood at $3.62 billion in 2024, is projected to rise to $3.97 billion in 2025. This growth signifies a compound annual growth rate (CAGR) of 9.9%. The notable advancement during the historical period can be ascribed to factors such as…
Unlocking New Horizons in Narcolepsy Treatment
The Business Research Company recently released a comprehensive report on the Global Narcolepsy Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, the narcolepsy market size has…
Narcolepsy Therapeutics Market Insights, Forecast to 2031
This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Narcolepsy Therapeutics market has been growing significantly in recent years, driven by a number of key factors, such as increasing demand for its products, expanding customer base, and technological advancements. This report provides a comprehensive analysis of the Narcolepsy Therapeutics market, including market size, trends, drivers and constraints, competitive aspects, and prospects…
Narcolepsy Drugs Market Trends and Dynamic 2028
Global Narcolepsy Drugs Market: Overview
The narcolepsy drug pipeline has been dotted with medications that can target several symptoms of neurological sleep disorder. These symptoms are characterized notably under narcolepsy type 1 and narcolepsy type 2. An array of psychostimulants have gained favor among clinicians as third-line therapy. The global narcolepsy market has made strides driven by advances adjunctive behavioral techniques.
To know Untapped Opportunities in the Market https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6068
Moreover, constant development of…
